A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma
- 1 December 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (12), 1805-1808
- https://doi.org/10.1016/0277-5379(89)90351-9
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988
- Reversible ocular toxicity related to tamoxifen therapyCancer, 1988
- Tamoxifen Retinopathy at Low DosageAmerican Journal of Ophthalmology, 1987
- Bilateral optic neuritis evolved during tamoxifen treatmentCancer, 1986
- DOUBLE-BLIND CONTROLLED TRIAL OF TAMOXIFEN THERAPY FOR MASTALGIAThe Lancet, 1986
- THE PREVENTION OF BREAST CANCERThe Lancet, 1986
- The Christie Hospital Tamoxifen (Nolvadex) adjuvant trial for operable breast carcinoma - 7-yr resultsEuropean Journal of Cancer and Clinical Oncology, 1985
- Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.BMJ, 1982
- Tamoxifen retinopathy.British Journal of Ophthalmology, 1981
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978